Polacheck and Cao publish in Clinical Pharmacology and Therapeutics

Drs. Polacheck and Cao discuss the opportunities and challenges associated with new approach methodologies (NAMs) in preclinical drug development. This perspective piece comes after nearly a year of discussion, planning, and collaboration between the Polacheck and Cao labs to develop organ-on-chip platforms that can replace or augment animal models in pre-clinical drug development. The perspective can be found here.